Combination strategy of gemcitabine with the dual PI3K/mTOR inhibitor NVP-BEZ235 in pancreatic cancer cells.
E. Hausmann
No relevant relationships to disclose
W. Glienke
No relevant relationships to disclose
L. Bergmann
No relevant relationships to disclose